Clinical
RSSArticles
-
Study Finds Increased Risk of Depression with Use of Oral Contraceptives
A population-based cohort study with data for more than 260,000 women revealed oral contraception use can increase the risk of depression, particularly during the first two years of its use. For adolescents, its use can increase later-in-life risk of depression, as well. Investigators said their results were consistent with a causal relationship between oral contraceptive use and depression.
-
People Can Safely Self-Manage Medication Abortion After 10 Weeks
Abortion care for women in their late first trimester and second trimester of pregnancy has been abolished in some states — even when the patient’s health or life is at risk during a miscarriage or other pregnancy crisis. As increasing numbers of people turn to self-managed abortion for ending their pregnancies, this option has not been seen as an alternative for U.S. women who are more than 10 weeks pregnant — until now.
-
What Is Next for the First OTC Birth Control Pill Approved by the FDA?
It took contraceptive care advocates more than two decades, but they achieved success on July 13, when the U.S. Food and Drug Administration approved Opill, the first over-the-counter hormonal birth control pill, for use in the United States.
-
Caregivers of Foster Youth Play Role in Contraceptive Decisions
Foster youth are vulnerable and at high risk of pregnancy. Reproductive health providers need to work with the youth and their caregivers to build a trusting relationship when discussing contraception.
-
This Leadless Dual-Chamber Pacing System Is Coming
The initial 90-day experience with a dual-chamber leadless pacemaker system showed reliable atrial pacing and atrioventricular synchrony, with complication rates similar to conventional lead-based systems.
-
Researchers Report on the Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator
An FDA-mandated post-approval study of the subcutaneous cardioverter-defibrillator system in a real-world population revealed excellent safety and efficacy over five years.
-
Clinical Outcomes of Left Bundle Branch Area Pacing vs. Biventricular Pacing
Researchers compared biventricular pacing to left bundle branch area pacing (LBBAP) for cardiac resynchronization among patients living with heart failure caused by reduced left ventricular ejection fraction, along with either LBB block or need for ventricular pacing. The combined endpoint of all-cause mortality rates or heart failure hospitalizations was significantly lower with LBBAP.
-
Detecting Left Ventricular Thrombi
A study of early post-ST-elevation myocardial infarction patients who underwent echocardiographic testing and cardiac MRI showed echo misses about two-thirds of cardiac MRI-discovered left ventricular thrombi. However, an echo apical wall motion score can identify most patients in whom echo may miss thrombi for the selective use of cardiac MRI.
-
Rates of Ad Hoc PCI Remain Higher for Multivessel and Left Main Disease
In this retrospective analysis of patients from the New York state percutaneous coronary intervention (PCI) and coronary artery bypass grafting databases, ad hoc PCI was performed frequently among patients with left main and multivessel disease. Also, variability in ad hoc PCI use among hospitals and physicians for these populations was high.
-
Nirsevimab-alip Injection (Beyfortus)
Nirsevimab can be prescribed to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants born during or entering their first RSV season.